The Sensex was up 382 points at 75,124.28 at open on April 9. This latest 5,000-point run in the index comes after just 82 days. Sensex had crossed the 70,000 mark in December 2023.
Read More
It has become fashionable to say elections and the upcoming Budget are priced in, says the CEO of WhiteOak Capital AMC. There is substantial upside potential in the coming months, which shouldn#39;t be overlooked or underestimated, he says.
Read More
Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024.
Read More
The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside.
Read More
The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility.
Read More
The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing.
Read More